To view the screening of familial adenomatous polyposis (FAP), click here
To view the screening of hereditary nonpolyposis colorectal cancer (HNPCC), click here
Early detection of premalignant colorectal masses or early-stage colorectal cancers is essential in treating these patients and possibly preventing cancer or colorectal cancer related death. According to the USPSTF (United States Preventive Services Task Force): Screening for colorectal cancer is recommended among adults older than 50 years of age and do not have an increased risk of developing the disease (average-risk adults).
According to the USPSTF (United States Preventive Services Task Force):[1]
Screening for colorectal cancer is recommended among adults older than 50 years of age and do not have an increased risk of developing the disease (average-risk adults).
Decision to screen for colorectal cancer among adults aged 76 to 85 years is an individual one.
Screening would be more beneficial for healthier individuals that are able to undergo possible treatment.
Screening for colorectal cancer among adults aged 86 years and older is not recommended.
No preference is given to one screening modality over the other
Decision should be shared and according to the patient's preferences when it comes to choosing an option.
Advanced adenomas are defined as being ≥10 mm, having villous histology, or having high grade dysplasia. Advanced neoplasia is defined as cancer or advanced adenoma[7].
Accuracy of screening tests to detect colorectal cancer and advanced adenomas[8].
↑Lieberman, David A. (2009). "Screening for Colorectal Cancer". New England Journal of Medicine. 361 (12): 1179–1187. doi:10.1056/NEJMcp0902176. ISSN0028-4793.